Biotechnology
How can we prevent future pandemics and accelerate progress in the life sciences?
COVID-19 has revealed both strengths and weaknesses in response to biological threats. On the one hand, the pandemic exposed how weak and ineffectual our public health systems are at controlling highly contagious airborne respiratory diseases. On the other hand, the urgency of the moment — combined with decades of previous investment — enabled us to deliver mRNA vaccines in less than nine months. Biotechnology contains much more low-hanging fruit that is ripe to be picked — if only we can implement the right public policies.
Featured Publication
Biotechnology
Protect Human Subjects, Not Bureaucracy
How investigator choice in IRBs can improve ethical oversight
Read the full report
Biotechnology
Featured Publication
Protect Human Subjects, Not Bureaucracy
How investigator choice in IRBs can improve ethical oversight
Read the full report
Read our recent publications
Biotechnology
Proxy Praxis: Why Validating an Endpoint Took 12 Years
Fragmented data and misaligned incentives are blocking faster clinical trials
Read the full report
Biotechnology
Proxy Praxis: How Surrogate Endpoints Can Speed Drug Development
A new series from the Institute for Progress
Read the full report
Biotechnology
How Scientific Incentives Stalled the Fight Against Antibiotic Resistance, and How We Can Fix It
A million-peptide database could help us solve antibiotic resistance.
Read the full report
Biotechnology Research Team
Biotechnology
The Case for Clinical Trial Abundance
A series of short papers outlining reform possibilities for America's clinical trials
Read the full report
Biotechnology
An Innovation Agenda for Addiction
We can advance the development of breakthrough medicines to reduce addiction at scale
Read the full report
Biotechnology
Securing Benchtop DNA Synthesizers
As the field of benchtop DNA synthesis evolves, it will require ongoing monitoring.
Read the full report
Biotechnology
Biosecurity in the Trump Era
We highlight five key moves the new administration could make to improve the nation's biosecurity
Read the full report
Biotechnology
The Triple Rapid Framework for Pandemic Diagnostics
Rapid reconfiguration, rapid deployment, and rapid results could help contain future outbreaks at their source
Read the full report
Biotechnology
Mapping America’s Biosurveillance
A comprehensive visual map of the entities that monitor biological threats across the U.S. federal government
Read the full report
Biotechnology
Congress Can Improve our Pandemic Preparedness
Strengthening the Federal Select Agent Program would mean better oversight of biotech laboratories
Read the full report
Biotechnology
Using PAHPA to Address Biosecurity Threats
A letter to House and Senate health committee leaders on making sure PAHPA mitigates biosecurity risks
Read the full report
Biotechnology
How Project NextGen Can Create Better Vaccines
A response to BARDA's request for information on the development of next generation medical countermeasures
Read the full report
Biotechnology
Preventing the Misuse of Breakthrough Health Research
A response to ARPA-H's request for information on ethical, legal, and social implications of technology development
Read the full report
Biotechnology
Making the CDC Modern
A response to the CDC's request for information on modernizing the agency
Read the full report
Biotechnology
Mitigating Risks from Dual-Use Research
A response to OSTP's request for information on developing a policy for research with certain pathogens
Read the full report
